Drug Overview: Singulair

Drug Overview: Singulair

  • February 2018 •
  • 16 pages •
  • Report ID: 5391448 •
  • Format: PDF
Drug Overview
Singulair (montelukast; Merck&Co/Kyorin) is an oral leukotriene D4 receptor antagonist used for prophylactic treatment of asthma. The drug is available in several oral formulations and is primarily taken as an add-on therapy for patients with refractory and/or allergic asthma.